Q4 2018 Arrowhead Pharmaceuticals Inc Earnings Call
שיחת ועידה Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc Conference call or earnings call will be held on 11/12/2018 via an 800 number (toll-free). During the earnings conference call's session Arrowhead Pharmaceuticals Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Arrowhead Pharmaceuticals Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
Arrowhead Research develops novel drugs to treat intractable diseases by silencing the genes that cause them. Using the industry's broadest portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference (RNAi) is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead's RNAi-based therapeutics leverage this natural pathway of gene silencing to target and shut down specific disease causing genes. Platform Delivery Technology The Dynamic Polyconjugate(TM) (DPC(TM)) platform is an RNAi delivery system that promotes high levels of target gene knockdown.קרא עוד שיחת ועידה